Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | UTHR |
---|---|---|
09:32 ET | 4168 | 316.67 |
09:34 ET | 100 | 319.7 |
09:36 ET | 700 | 321.8 |
09:38 ET | 300 | 321.8 |
09:39 ET | 1208 | 321.65 |
09:41 ET | 100 | 321.72 |
09:43 ET | 796 | 320.97 |
09:48 ET | 200 | 321.02 |
09:50 ET | 700 | 321.75 |
09:54 ET | 400 | 321.47 |
09:56 ET | 100 | 321.41 |
09:57 ET | 1520 | 320.82 |
09:59 ET | 700 | 320.24 |
10:01 ET | 1000 | 320.005 |
10:03 ET | 200 | 319.775 |
10:06 ET | 1544 | 319.36 |
10:08 ET | 500 | 319.015 |
10:10 ET | 300 | 317.9 |
10:12 ET | 200 | 318.06 |
10:14 ET | 1200 | 318.57 |
10:15 ET | 100 | 318.565 |
10:17 ET | 394 | 319.05 |
10:19 ET | 388 | 319.18 |
10:21 ET | 100 | 319.625 |
10:24 ET | 700 | 320.235 |
10:26 ET | 400 | 320.115 |
10:28 ET | 300 | 320.11 |
10:30 ET | 4640 | 319.2 |
10:32 ET | 392 | 319.17 |
10:33 ET | 683 | 318.5784 |
10:35 ET | 400 | 318.8 |
10:37 ET | 600 | 318.27 |
10:39 ET | 3693 | 318.05 |
10:42 ET | 978 | 318.14 |
10:44 ET | 300 | 318.045 |
10:46 ET | 800 | 318.41 |
10:48 ET | 235 | 318.505 |
10:50 ET | 900 | 318.46 |
10:51 ET | 400 | 320.385 |
10:53 ET | 600 | 320.075 |
10:55 ET | 349 | 320.65 |
10:57 ET | 500 | 320.56 |
11:00 ET | 649 | 320.605 |
11:02 ET | 300 | 320.595 |
11:04 ET | 400 | 320.59 |
11:06 ET | 1090 | 320.59 |
11:08 ET | 557 | 320.59 |
11:09 ET | 2909 | 320.06 |
11:11 ET | 1458 | 319.59 |
11:13 ET | 513 | 319.08 |
11:18 ET | 512 | 319.455 |
11:20 ET | 300 | 319.48 |
11:22 ET | 400 | 319.95 |
11:24 ET | 800 | 319.685 |
11:26 ET | 3020 | 318.63 |
11:27 ET | 1992 | 319.095 |
11:29 ET | 500 | 318.995 |
11:31 ET | 100 | 318.49 |
11:36 ET | 300 | 318.57 |
11:38 ET | 585 | 318.78 |
11:40 ET | 900 | 319.099 |
11:42 ET | 1010 | 319.06 |
11:44 ET | 300 | 319.045 |
11:45 ET | 100 | 319.155 |
11:47 ET | 900 | 319.27 |
11:49 ET | 2227 | 319.055 |
11:51 ET | 400 | 318.89 |
11:54 ET | 200 | 318.69 |
11:58 ET | 522 | 318.3479 |
12:00 ET | 312 | 318.34 |
12:02 ET | 534 | 318.27 |
12:03 ET | 3337 | 318.25 |
12:05 ET | 966 | 318.34 |
12:07 ET | 1675 | 318.4545 |
12:09 ET | 1000 | 319.15 |
12:12 ET | 200 | 319.27 |
12:14 ET | 146 | 319.015 |
12:16 ET | 400 | 318.98 |
12:18 ET | 600 | 319.375 |
12:20 ET | 1796 | 319.64 |
12:21 ET | 1740 | 319.43 |
12:23 ET | 401 | 319.185 |
12:25 ET | 1516 | 318.5516 |
12:27 ET | 200 | 319.18 |
12:30 ET | 200 | 319.17 |
12:34 ET | 200 | 318.66 |
12:36 ET | 456 | 318.825 |
12:38 ET | 754 | 318.815 |
12:39 ET | 400 | 318.96 |
12:41 ET | 100 | 318.71 |
12:43 ET | 358 | 318.815 |
12:45 ET | 300 | 318.785 |
12:48 ET | 1300 | 318.91 |
12:50 ET | 1417 | 318.36 |
12:52 ET | 987 | 318.5 |
12:54 ET | 100 | 318.585 |
12:57 ET | 100 | 318.35 |
12:59 ET | 200 | 318.275 |
01:01 ET | 2000 | 318.715 |
01:03 ET | 400 | 318.7 |
01:08 ET | 100 | 318.55 |
01:10 ET | 1100 | 319.29 |
01:12 ET | 1300 | 319.49 |
01:17 ET | 300 | 319.52 |
01:19 ET | 1100 | 319.78 |
01:24 ET | 600 | 320.07 |
01:26 ET | 2100 | 319.67 |
01:28 ET | 1019 | 319.25 |
01:30 ET | 1000 | 319.05 |
01:32 ET | 1300 | 318.94 |
01:33 ET | 960 | 319.15 |
01:35 ET | 300 | 318.79 |
01:37 ET | 700 | 318.73 |
01:39 ET | 855 | 318.22 |
01:44 ET | 230 | 318.34 |
01:46 ET | 500 | 318.13 |
01:48 ET | 1705 | 318.93 |
01:50 ET | 502 | 318.875 |
01:51 ET | 200 | 319.06 |
01:53 ET | 1400 | 318.78 |
01:55 ET | 800 | 318.49 |
01:57 ET | 1605 | 318.63 |
02:00 ET | 100 | 318.395 |
02:02 ET | 100 | 318.23 |
02:04 ET | 154 | 318.13 |
02:06 ET | 100 | 318.07 |
02:08 ET | 1700 | 318.4 |
02:09 ET | 500 | 318.98 |
02:11 ET | 100 | 318.875 |
02:13 ET | 100 | 319.07 |
02:15 ET | 100 | 318.92 |
02:18 ET | 800 | 319.51 |
02:20 ET | 300 | 319.37 |
02:22 ET | 100 | 319.37 |
02:24 ET | 800 | 319.42 |
02:26 ET | 500 | 319.15 |
02:27 ET | 660 | 319.16 |
02:29 ET | 600 | 319.28 |
02:31 ET | 465 | 319.13 |
02:33 ET | 900 | 319.16 |
02:36 ET | 400 | 319.1568 |
02:38 ET | 3476 | 319.07 |
02:40 ET | 400 | 318.85 |
02:42 ET | 200 | 318.67 |
02:44 ET | 700 | 319.08 |
02:45 ET | 300 | 318.99 |
02:47 ET | 1000 | 319.005 |
02:49 ET | 1300 | 319.255 |
02:51 ET | 500 | 319.1025 |
02:54 ET | 300 | 319.235 |
02:56 ET | 700 | 319.245 |
02:58 ET | 1283 | 319.09 |
03:00 ET | 250 | 319.115 |
03:02 ET | 1276 | 318.835 |
03:03 ET | 2191 | 318.21 |
03:05 ET | 1921 | 318.4 |
03:07 ET | 200 | 318.16 |
03:09 ET | 330 | 318.4 |
03:12 ET | 1611 | 318.58 |
03:14 ET | 400 | 318.75 |
03:16 ET | 700 | 319.12 |
03:18 ET | 200 | 319.1 |
03:20 ET | 4927 | 319.405 |
03:21 ET | 100 | 319.38 |
03:23 ET | 700 | 319.11 |
03:25 ET | 503 | 318.96 |
03:27 ET | 876 | 319.265 |
03:30 ET | 3058 | 319.535 |
03:32 ET | 225 | 319.58 |
03:34 ET | 2109 | 319.5625 |
03:36 ET | 411 | 319.765 |
03:38 ET | 1100 | 319.76 |
03:39 ET | 2426 | 319.78 |
03:41 ET | 639 | 319.66 |
03:43 ET | 2350 | 319.92 |
03:45 ET | 6191 | 320.01 |
03:48 ET | 1838 | 319.355 |
03:50 ET | 6642 | 320.035 |
03:52 ET | 7532 | 319.75 |
03:54 ET | 1215 | 319.56 |
03:56 ET | 7648 | 319.25 |
03:57 ET | 3328 | 319.105 |
03:59 ET | 7455 | 319.04 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
United Therapeutics Corp | 14.2B | 15.1x | +8.22% |
Biomarin Pharmaceutical Inc | 16.1B | 80.4x | --- |
Neurocrine Biosciences Inc | 13.6B | 37.1x | +62.04% |
Beigene Ltd | 17.1B | -19.9x | --- |
Medpace Holdings Inc | 12.6B | 41.5x | +35.10% |
Qiagen NV | 9.1B | 27.3x | +12.66% |
United Therapeutics Corporation is a pharmaceutical company. It markets and sells commercial therapies to treat pulmonary arterial hypertension (PAH): Tyvaso DPI (treprostinil) Inhalation Powder (Tyvaso DPI); Tyvaso (treprostinil) Inhalation Solution (nebulized Tyvaso), which includes the Tyvaso Inhalation System; Remodulin (treprostinil) Injection (Remodulin); Orenitram (treprostinil) Extended-Release Tablets (Orenitram); and Adcirca (tadalafil) Tablets (Adcirca). Tyvaso DPI and nebulized Tyvaso are also approved to treat pulmonary hypertension associated with interstitial lung disease (PH-ILD). It also markets and sells an oncology product, Unituxin (dinutuximab) Injection (Unituxin) for treatment of high-risk neuroblastoma, and the Remunity Pump for Remodulin (Remunity). Tyvaso DPI is a drug-device combination product that incorporates the dry powder formulation technology and Dreamboat inhalation device technology used in MannKind’s Afrezza (insulin human) Inhalation Powder.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $14.2B |
---|---|
Revenue (TTM) | $2.5B |
Shares Outstanding | 44.4M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.56 |
EPS | $21.13 |
Book Value | $127.23 |
P/E Ratio | 15.1x |
Price/Sales (TTM) | 5.7 |
Price/Cash Flow (TTM) | 12.8x |
Operating Margin | 50.31% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.